Sara Coggon
GlaxoSmithKline (United Kingdom)(GB)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology, Peptidase Inhibition and Analysis, Pharmacological Receptor Mechanisms and Effects, Neurotransmitter Receptor Influence on Behavior
Most-Cited Works
- → Central Nervous System Drug Disposition: The Relationship between in Situ Brain Permeability and Brain Free Fraction(2007)282 cited
- → New quinoline NK3 receptor antagonists with CNS activity(2008)58 cited
- → SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4′-{[(2-phenylethyl)amino]methyl}-4-biphenylyl)methyl]propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: Evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain(2006)51 cited
- → Discovery of a potent and selective 5-ht5A receptor antagonist by high-throughput chemistry(2005)41 cited
- → Novel Selective Inhibitors of Neutral Endopeptidase for the Treatment of Female Sexual Arousal Disorder. Synthesis and Activity of Functionalized Glutaramides(2006)38 cited
- → Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder(2006)21 cited
- → Locomotor reactivity to a novel environment and sensitivity to MK-801 in five strains of mice(2008)20 cited
- → Analysis of the pharmacokinetic/pharmacodynamic relationship of a small molecule CXCR3 antagonist, NBI‐74330, using a murine CXCR3 internalization assay(2007)20 cited
- → The Discovery of Small Molecule Inhibitors of Neutral Endopeptidase. Structure–Activity Studies on Functionalized Glutaramides(2005)7 cited
- → Discovery of a Potent and Selective 5‐ht5A Receptor Antagonist (I) by High‐Throughput Chemistry.(2005)